Sofinnova Investments, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001631134

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q4 2025 · 60 positions · Total reported value $2.32B · Top-10 concentration 54.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 67.1% · 13 new · 16 cut · 26 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 98.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +12.4% · vs SPY -2.4% · Prev Value $2.38B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, Sofinnova Investments, Inc. disclosed 60 equity positions with a combined reported value of $2.32B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 54.2% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were NTRA ($355.15M), JAZZ ($163.18M), AZN ($150.06M). By sector, the heaviest allocations are Health Care 92.3%, Other 7.7%. Versus the prior quarter, allocation shifted toward Health Care (+5.4pp) and away from Other (-5.4pp).

Versus the prior quarter, Sofinnova Investments, Inc. opened 13 new positions, trimmed 16 and fully exited 26, a turnover rate of 67.1% of positions. The portfolio's overlap with the prior quarter was 70% of names.

The largest new positions opened in Q4 2025 were BMY ($81.61M), LLY ($66.26M), BMRN ($41.43M).

Of the 26 positions fully exited versus the prior quarter, the largest were GILD ($139.01M), BSX ($55.59M), IBB ($46.92M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • BMY BRISTOL-MYERS SQUIBB CO · $81.61M
  • LLY ELI LILLY & CO · $66.26M
  • BMRN BIOMARIN PHARMACEUTICAL INC · $41.43M
  • CNTA CENTESSA PHARMACEUTICALS PLC · $27.62M
  • ALC ALCON AG · $26.21M
  • AMLX AMYLYX PHARMACEUTICALS INC · $6.37M
  • MASI MASIMO CORP · $6.01M
  • XENE XENON PHARMACEUTICALS INC · $2.68M

Fully Exited (vs previous quarter)

  • GILD GILEAD SCIENCES INC · prev qtr: $139.01M · history
  • BSX BOSTON SCIENTIFIC CORP · prev qtr: $55.59M
  • IBB ISHARES TR · prev qtr: $46.92M
  • XBI SPDR SERIES TRUST · prev qtr: $40.08M
  • AKRO AKERO THERAPEUTICS INC · prev qtr: $22.49M
  • SMMT SUMMIT THERAPEUTICS INC · prev qtr: $18.59M
  • MRUS MERUS N V · prev qtr: $15.70M
  • PTCT PTC THERAPEUTICS INC · prev qtr: $11.47M

Insider Transactions (Form 4)

Latest Sofinnova Investments, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sofinnova Investments, Inc., based in Menlo Park, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 56 positions worth $1.88B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: MENLO PARK, CA, United States
  • SEC registration: 801-110134 (status: Approved), registered 2017-03-22
  • Regulatory AUM (Form ADV): $5.37B as of 2026-03-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 3 hedge funds
  • Website: sofinnova.com

Portfolio Structure

  • 56 positions · $1.88B reported value (Q2 2026)
  • Top 10 holdings = 59.2% of reported value
  • Largest position: NTRA (NATERA INC) at 22.4%
  • Average position size: $33.52M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 13 new, 14 added, 16 reduced, 26 exited
  • 13 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.3%
Other 7.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.55M $355.15M 15.31%
15.31%
Hold
2 959.86K $163.18M 7.04%
7.04%
Add
3 1.63M $150.06M 6.47%
6.47%
Add
4 2.79M $141.49M 6.10%
6.10%
Hold
5 1.51M $81.61M 3.52%
3.52%
New
6 157.64K $76.81M 3.31%
3.31%
Add
7 164.59K $74.62M 3.22%
3.22%
Add
8 317.78K $72.61M 3.13%
3.13%
Add
9 126.97K $71.91M 3.10%
3.10%
Add
10 1.97M $70.10M 3.02%
3.02%
Reduce
11 61.65K $66.26M 2.86%
2.86%
New
12 1.90M $57.78M 2.49%
2.49%
Reduce
13 720.45K $55.11M 2.38%
2.38%
Reduce
14 745.12K $53.75M 2.32%
2.32%
Reduce
15 2.25M $44.09M 1.90%
1.90%
Add
16 697.13K $41.43M 1.79%
1.79%
New
17 534.85K $40.37M 1.74%
1.74%
Reduce
18 180.26K $39.82M 1.72%
1.72%
Add
19 125.72K $37.06M 1.60%
1.60%
Reduce
20 3.44M $36.07M 1.55%
1.55%
Add
21 454.66K $35.92M 1.55%
1.55%
Add
22 1.62M $34.76M 1.50%
1.50%
Add
23 1.70M $34.14M 1.47%
1.47%
Hold
24 288.13K $32.53M 1.40%
1.40%
Reduce
25 885.12K $30.60M 1.32%
1.32%
Reduce
26 2.29M $30.35M 1.31%
1.31%
Hold
27 299.42K $29.86M 1.29%
1.29%
Add
28 271.39K $29.05M 1.25%
1.25%
Add
29 1.10M $27.62M 1.19%
1.19%
New
30 553.10K $27.49M 1.19%
1.19%
Add
31 156.80K $27.29M 1.18%
1.18%
Add
32 332.52K $26.21M 1.13%
1.13%
New
33 1.10M $26.13M 1.13%
1.13%
Reduce
34 378.22K $25.10M 1.08%
1.08%
Reduce
35 745.17K $20.68M 0.89%
0.89%
Add
36 438.63K $18.55M 0.80%
0.80%
Add
37 3.37M $18.07M 0.78%
0.78%
Add
38 734.58K $15.94M 0.69%
0.69%
Reduce
39 287.69K $13.95M 0.60%
0.60%
Add
40 160.88K $13.20M 0.57%
0.57%
Add
41 437.82K $10.86M 0.47%
0.47%
Reduce
42 101.44K $10.30M 0.44%
0.44%
Reduce
43 111.01K $8.82M 0.38%
0.38%
Add
44 527.10K $6.37M 0.28%
0.28%
New
45 46.20K $6.01M 0.26%
0.26%
New
46 176.51K $4.22M 0.18%
0.18%
Add
47 222.65K $3.16M 0.14%
0.14%
Hold
48 158.18K $2.69M 0.12%
0.12%
Reduce
49 59.90K $2.68M 0.12%
0.12%
New
50 153.32K $2.62M 0.11%
0.11%
New

FAQ

What did Sofinnova Investments, Inc. buy in 2025-Q4?

In its 2025-Q4 13F filing, Sofinnova Investments, Inc. reported 60 equity positions worth $2.32B in aggregate; its largest disclosed positions were NTRA ($355.15M), JAZZ ($163.18M), AZN ($150.06M).

How large is Sofinnova Investments, Inc.'s portfolio?

Sofinnova Investments, Inc. reported $2.32B of long equity holdings across 60 positions as of 2025-Q4. Top-10 holdings account for 54.2% of reported value.

What is Sofinnova Investments, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sofinnova-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →